These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34981827)

  • 1. The promise of COVID-19 vaccines. Authors' reply.
    Sokolska JM; Kurcz J; Kosmala W
    Kardiol Pol; 2022; 80(1):111-112. PubMed ID: 34981827
    [No Abstract]   [Full Text] [Related]  

  • 2. ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2021 Jun; 397(10291):2248. PubMed ID: 34119059
    [No Abstract]   [Full Text] [Related]  

  • 3. Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection.
    Harder T; Koch J; Vygen-Bonnet S; Külper-Schiek W; Pilic A; Reda S; Scholz S; Wichmann O
    Euro Surveill; 2021 Sep; 26(35):. PubMed ID: 34477051
    [No Abstract]   [Full Text] [Related]  

  • 4. Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".
    García LY; Cerda AA
    Appl Health Econ Health Policy; 2021 Jul; 19(4):623-624. PubMed ID: 33973149
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply.
    Kasi SG; Shah A
    Indian Pediatr; 2021 Feb; 58(2):195. PubMed ID: 33632967
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply.
    Alexander JL; Kennedy NA; Lees CW; Ahmad T; Powell N;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):523-524. PubMed ID: 34119033
    [No Abstract]   [Full Text] [Related]  

  • 7. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565
    [No Abstract]   [Full Text] [Related]  

  • 8. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Logunov DY; Dolzhikova IV; Shcheblyakov DV
    Lancet; 2021 May; 397(10288):1883-1884. PubMed ID: 33991474
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Logunov DY; Dolzhikova IV; Tukhvatullin AI; Shcheblyakov DV
    Lancet; 2020 Oct; 396(10256):e54-e55. PubMed ID: 32971043
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Buchbinder SP; McElrath MJ; Dieffenbach C; Corey L
    Lancet; 2022 Apr; 399(10333):e36. PubMed ID: 35397867
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Jun; 397(10291):2249-2250. PubMed ID: 34119061
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
    Thompson MG; Grant L; Meece J;
    N Engl J Med; 2021 Nov; 385(19):1819-1821. PubMed ID: 34614323
    [No Abstract]   [Full Text] [Related]  

  • 13. Misunderstanding poor adherence to COVID-19 vaccination in Africa - Authors' reply.
    Mutombo PN; Fallah MP; Munodawafa D; Kabel A; Houeto D; Goronga T; Mweemba O; Balance G; Onya H; Kamba RS; Chipimo M; Kayembe JN; Akanmori B
    Lancet Glob Health; 2022 Jun; 10(6):e795. PubMed ID: 35561716
    [No Abstract]   [Full Text] [Related]  

  • 14. Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.
    Wong NS; Wong BCK; Chan JMC; Wong KH; Tsang OTY; Lee SS; Chan DPC
    AIDS; 2022 Oct; 36(12):1747-1748. PubMed ID: 36052544
    [No Abstract]   [Full Text] [Related]  

  • 15. The Covid-19 Vaccine-Development Multiverse. Reply.
    Heaton PM
    N Engl J Med; 2021 Feb; 384(7):682. PubMed ID: 33503339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reply to "Defining priorities, the case of of COVID-19 vaccine"].
    Indolfi C; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Romeo F; Sinagra G; Filardi PP
    G Ital Cardiol (Rome); 2021 Jun; 22(6):510-511. PubMed ID: 34037598
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet).
    Korn L; Böhm R; Betsch C
    Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33762431
    [No Abstract]   [Full Text] [Related]  

  • 18. BNT162b2 Covid-19 Vaccine in Adolescents. Reply.
    Frenck RW; Dormitzer PR; Gurtman A
    N Engl J Med; 2021 Sep; 385(14):1343. PubMed ID: 34525284
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    Absalon J; Koury K; Gruber WC
    N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to: "Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!".
    Rabinowich L; Shibolet O; Katchman H
    J Hepatol; 2022 Jan; 76(1):239-240. PubMed ID: 34634386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.